...DALLAS Texas and NUTLEY N.J. April 23 2007 /PRNewswire/ --An acti... Nephrology nurses serve a pivotal role in the care of patientswith r...About the Analysis ...The primary objective of this analysis was to evaluate time andassoci...

DALLAS, Texas and NUTLEY, N.J., April 23, 2007 /PRNewswire/ --
An activity-based cost analysis demonstrated that if a renal anemia
treatment administered once every four weeks replaced thrice weekly
administration of epoetin alfa, hemodialysis centers may save an
estimated 802 nursing hours and more than $44,000 per year per 100
patients. These data, from a multi-center prospective analysis of
anemia management in hemodialysis patients, were presented today
during an oral session at the American Nephrology Nurses'
Association (ANNA) 38th National Symposium in Dallas, TX.

"Nephrology nurses serve a pivotal role in the care of patients
with renal anemia associated with chronic kidney disease," said
Sheila Doss, RN, CNN, CCRA, Nursing Director of Research, Satellite
Healthcare, Inc. and one of the lead study investigators. "This
analysis shows that a once-monthly anemia treatment may
significantly reduce the time nurses spend managing the
administration of renal anemia medication, allowing us to devote
more time to other important aspects of patient care."

About the Analysis

The primary objective of this analysis was to evaluate time and
associated in-center supply costs observed while administering
epoetin alfa three times a week in patients with renal anemia
receiving dialysis, and to model the potential time and cost
savings that could be expected if patients switched to a once every
four week renal anemia treatment. Researchers concluded that in-
center treatment of renal anemia three times a week can be
labor-intensive and expensive. The analysis showed that if 100
percent of the patients were given a renal anemia treatment that
could be dosed once every four weeks, a greater than 10-fold
reduction in time and a similar drop in corresponding costs
associated with renal anemia management could result. The
researchers noted that time savings are the major contributor to
total cost savings.
The second component of total cost, non-drug
supply costs, are also reduced greater than 10-fold with the model
of a once-monthly anemia treatment.

Chronic Kidney Disease and Renal Anemia

According to the National Kidney Foundation, 20 million
Americans have chronic kidney disease (CKD) and another 20 million
are at increased risk for the condition. CKD is considered a rising
global epidemic because it is linked to two of the fastest-growing
diseases -- diabetes and hypertension. An often under-diagnosed
condition, CKD is called a disease multiplier because many of its
risk factors are also complications of the disease itself, creating
a relentless spiral in which one condition can lead to the
exacerbation of the other and, ultimately, to death. In particular,
renal anemia, diabetes and cardiovascular disease frequently play
this double role.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the
U.S. pharmaceuticals headquarters of the Roche Group, one of the
world's leading research-oriented healthcare groups with core
businesses in pharmaceuticals and diagnostics. For more than 100
years in the U.S., Roche has been committed to developing
innovative products and services that address prevention, diagnosis
and treatment of diseases, thus enhancing people's health and
quality of life. An employer of choice, in 2006, Roche was named
one of the Top 20 Employers (Science magazine), ranked the No. 1
Company to Sell For (Selling Power), and one of AARP's Top
Companies for Older Workers, and in 2005, Roche was named one of
Fortune magazine's Best Companies to Work For in America. For
additional information about the U.S. pharmaceuticals business,
visit our websites: http://www.rocheusa.com or
www.roche.us.

All trademarks used or mentioned in this release are protected
by law.

(Date:7/26/2017)... Medical Aesthetics, a leading medical aesthetic clinic in Singapore ... several skin conditions from the inside. The natural process ... The skin becomes more transparent due to the thinning of the ... from the sun contributes to aging skin, causing age spots and ... ...

(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, ... that it was acquired by Advantage Solutions. The Data Council’s IX-ONE platform ... include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council will ...